Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2025-12-25 @ 4:59 AM
NCT ID:
NCT03286218
Eligibility Criteria:
Inclusion Criteria:
* Are overtly healthy males or females, as determined by medical history and physical examination.
* Have a body mass index (BMI) of 18 to 32 kilograms per meter squared (kg/m²) inclusive, at the time of screening.
* Must be recreational drug user and agree not to consume any recreational drugs during the study.
Exclusion Criteria:
* Have known allergies to lasmiditan, alprazolam, related compounds, or any components of the formulation, or a history of significant atopy.
* Are currently seeking or participating in treatment for addiction or substance-related disorders, or have recovered from substance abuse disorder.
* Are currently taking excluded prescription or over-the-counter (OTC) medications.
* Have a history of significant sleep disorder, including sleep apnea or narcolepsy.
* Have a history of orthostatic hypotension, vertigo, syncope, or presyncope.
* Have a history of brain injury, including a history of concussions.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT03286218
Study Brief:
Protocol Section:
NCT03286218